Review



medical research  (Revvity)


Bioz Verified Symbol Revvity is a verified supplier
Bioz Manufacturer Symbol Revvity manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Revvity medical research
    Medical Research, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 37229 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/zebrafish+microarray+platform/IVIS+optical+imaging+platform/pmc06354590-762-39-47
    Average 96 stars, based on 37229 article reviews
    medical research - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Mouse Assay:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Control:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Imaging:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Injection:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Negative Control:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Fluorescence:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    In Vivo:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Software:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Ex Vivo:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Labeling:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    In Vivo Imaging:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Suspension:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Sequencing:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Luciferase:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2

    Mutagenesis:

    Article Title: A user-friendly strategy to engineer tailored intermediate strains for overcoming combined type I and type II restriction-modification barriers in Staphylococcus aureus
    Article Snippet: se receiving only the substrate served as the negative control. Three minutes after substrate injection, bioluminescence signals from the kidneys were detected on the dorsal side of the mouse using an IVIS Lumina LT imaging system. The preparation of the HFZ substrate and the image acquisition parameters were based on a previous study [ 18 ]. Ethical approval Female BALB/c mice (6–8 weeks old, 16–2



    Similar Products

    zebrafish microarray platform  (Agilent technologies)
    90
    Agilent technologies zebrafish microarray platform
    Of 12261 potential unique genes, the mRNA expression of 1313 were found to be statistically significantly changed at 24 hpf, with 583 downregulated (grey) and 730 upregulated (black). 836 genes were changed with statistical significance at 36 hpf, of which 243 were downregulated and 593 were upregulated. (n=3 pools of 25 embryos used for <t>microarray</t> analysis, P≤0.05, Students t -test with Benjamini-Hochberg false-discovery rate correction).
    Zebrafish Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/zebrafish+microarray+platform/pmc03858477-91-29-28
    Average 90 stars, based on 1 article reviews
    zebrafish microarray platform - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    zebrafish 4 × 180 k microarray platform  (Agilent technologies)
    90
    Agilent technologies zebrafish 4 × 180 k microarray platform
    Of 12261 potential unique genes, the mRNA expression of 1313 were found to be statistically significantly changed at 24 hpf, with 583 downregulated (grey) and 730 upregulated (black). 836 genes were changed with statistical significance at 36 hpf, of which 243 were downregulated and 593 were upregulated. (n=3 pools of 25 embryos used for <t>microarray</t> analysis, P≤0.05, Students t -test with Benjamini-Hochberg false-discovery rate correction).
    Zebrafish 4 × 180 K Microarray Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/zebrafish+microarray+platform/pm36126741-89-18-20
    Average 90 stars, based on 1 article reviews
    zebrafish 4 × 180 k microarray platform - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    zebrafish-specific microarray platform arrayxs zebrafish v1 zv9  (OakLabs Inc)
    90
    OakLabs Inc zebrafish-specific microarray platform arrayxs zebrafish v1 zv9
    Of 12261 potential unique genes, the mRNA expression of 1313 were found to be statistically significantly changed at 24 hpf, with 583 downregulated (grey) and 730 upregulated (black). 836 genes were changed with statistical significance at 36 hpf, of which 243 were downregulated and 593 were upregulated. (n=3 pools of 25 embryos used for <t>microarray</t> analysis, P≤0.05, Students t -test with Benjamini-Hochberg false-discovery rate correction).
    Zebrafish Specific Microarray Platform Arrayxs Zebrafish V1 Zv9, supplied by OakLabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/zebrafish+microarray+platform/arrayxs+zebrafish+microarray+slides/bio_rxiv__687798-42-12-4
    Average 90 stars, based on 1 article reviews
    zebrafish-specific microarray platform arrayxs zebrafish v1 zv9 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    zebrafish oligo microarray 4×44k platform  (Agilent technologies)
    90
    Agilent technologies zebrafish oligo microarray 4×44k platform
    Of 12261 potential unique genes, the mRNA expression of 1313 were found to be statistically significantly changed at 24 hpf, with 583 downregulated (grey) and 730 upregulated (black). 836 genes were changed with statistical significance at 36 hpf, of which 243 were downregulated and 593 were upregulated. (n=3 pools of 25 embryos used for <t>microarray</t> analysis, P≤0.05, Students t -test with Benjamini-Hochberg false-discovery rate correction).
    Zebrafish Oligo Microarray 4×44k Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/zebrafish+microarray+platform/pmc03413166-221-8-7
    Average 90 stars, based on 1 article reviews
    zebrafish oligo microarray 4×44k platform - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Of 12261 potential unique genes, the mRNA expression of 1313 were found to be statistically significantly changed at 24 hpf, with 583 downregulated (grey) and 730 upregulated (black). 836 genes were changed with statistical significance at 36 hpf, of which 243 were downregulated and 593 were upregulated. (n=3 pools of 25 embryos used for microarray analysis, P≤0.05, Students t -test with Benjamini-Hochberg false-discovery rate correction).

    Journal: PLoS ONE

    Article Title: The Transcriptomics of Glucocorticoid Receptor Signaling in Developing Zebrafish

    doi: 10.1371/journal.pone.0080726

    Figure Lengend Snippet: Of 12261 potential unique genes, the mRNA expression of 1313 were found to be statistically significantly changed at 24 hpf, with 583 downregulated (grey) and 730 upregulated (black). 836 genes were changed with statistical significance at 36 hpf, of which 243 were downregulated and 593 were upregulated. (n=3 pools of 25 embryos used for microarray analysis, P≤0.05, Students t -test with Benjamini-Hochberg false-discovery rate correction).

    Article Snippet: To better understand of the molecular mechanisms involved, we investigated changes in the developmental transcriptome prior to hatch, in response to morpholino oligonucleotide knockdown of GR using the Agilent zebrafish microarray platform.

    Techniques: Expressing, Microarray

    qPCR analysis was performed on 7 genes to confirm the transcript abundance seen with the microarray analysis. The selected genes were bmp7a (A), f5 (B) , ff1d (C), myom1a (D), pomca (E), star (F), mc1r (G). Data is presented as mean ± standard error of the mean (normalized to β-actin, SEM; n=5-7 pools of 25 embryos each); * denotes statistical significance ( t -test, p<0.05). (See for fold-changes and p-values).

    Journal: PLoS ONE

    Article Title: The Transcriptomics of Glucocorticoid Receptor Signaling in Developing Zebrafish

    doi: 10.1371/journal.pone.0080726

    Figure Lengend Snippet: qPCR analysis was performed on 7 genes to confirm the transcript abundance seen with the microarray analysis. The selected genes were bmp7a (A), f5 (B) , ff1d (C), myom1a (D), pomca (E), star (F), mc1r (G). Data is presented as mean ± standard error of the mean (normalized to β-actin, SEM; n=5-7 pools of 25 embryos each); * denotes statistical significance ( t -test, p<0.05). (See for fold-changes and p-values).

    Article Snippet: To better understand of the molecular mechanisms involved, we investigated changes in the developmental transcriptome prior to hatch, in response to morpholino oligonucleotide knockdown of GR using the Agilent zebrafish microarray platform.

    Techniques: Microarray

    List of genes confirmed using microarray and qPCR with fold-changes and p-values.

    Journal: PLoS ONE

    Article Title: The Transcriptomics of Glucocorticoid Receptor Signaling in Developing Zebrafish

    doi: 10.1371/journal.pone.0080726

    Figure Lengend Snippet: List of genes confirmed using microarray and qPCR with fold-changes and p-values.

    Article Snippet: To better understand of the molecular mechanisms involved, we investigated changes in the developmental transcriptome prior to hatch, in response to morpholino oligonucleotide knockdown of GR using the Agilent zebrafish microarray platform.

    Techniques: Microarray